These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3434050)

  • 41. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 42. The specificity of serum antibodies to the haemagglutinin of influenza B viruses induced by vaccination.
    Creţescu L; Ioniţă E; Niculescu IT; Coban V; Bogdan C
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):27-33. PubMed ID: 3324992
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.
    Rota PA; De BK; Shaw MW; Black RA; Gamble WC; Kendal AP
    Virus Res; 1990 Apr; 16(1):83-93. PubMed ID: 2349834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative clinical trial of vaccines against avian influenza].
    Zverev VV; Katlinskiĭ AV; Kostinov MP; Zhirova SN; Erofeeva MK; Stukova MA; Korovkin SA; Mel'nikov SIa; Semchenko AV; Mironov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):10-6. PubMed ID: 17672124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The choice of the optimal schedules in the vaccination procedure against influenza in elderly subjects].
    Burtseva EI; Slepushkin AN; Beliaev AL; Kolobukhina LV; Merkulova LN; Boltenko VV; Stepnova AI; Beregovskiĭ NA; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):40-5. PubMed ID: 9783399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.
    Zahradnik JM; Kasel JA; Martin RR; Six HR; Cate TR
    J Med Virol; 1983; 11(4):277-85. PubMed ID: 6875521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.
    Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD
    Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.
    Treanor JJ; Betts RF; Smith GE; Anderson EL; Hackett CS; Wilkinson BE; Belshe RB; Powers DC
    J Infect Dis; 1996 Jun; 173(6):1467-70. PubMed ID: 8648221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
    Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.
    Steinhoff MC; Fries LF; Karron RA; Clements ML; Murphy BR
    J Clin Microbiol; 1993 Apr; 31(4):836-8. PubMed ID: 8463393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination].
    Rudenko LG; Shvartsman IaS; Ispolatova AV; Grigor'eva EP; Drinevskiĭ VP
    Vopr Virusol; 1989; 34(1):29-34. PubMed ID: 2728404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

  • 56. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
    Chow TC; Beutner KR; Ogra PL
    Infect Immun; 1979 Jul; 25(1):103-9. PubMed ID: 478632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.
    Gorse GJ; Otto EE; Powers DC; Chambers GW; Eickhoff CS; Newman FK
    J Infect Dis; 1996 Feb; 173(2):285-90. PubMed ID: 8568287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of purified influenza subunit vaccines and relation to the major antigenic determinants on the hemagglutinin molecule.
    Couch RB; Webster RG; Kasel JA; Cate TR
    J Infect Dis; 1979 Oct; 140(4):553-9. PubMed ID: 92511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
    Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC
    J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiological investigations in young children's communities concerning the efficiency of prophylactic immunization with inactivated influenza vaccine (I.C. 80) in a preepidemic season.
    Măgureanu E; Busuioc C; Ionescu V; Tisu A; Coban V; Stoicescu A; Guguianu E; Calomfirescu N; Bordeianu V; Toma C
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):233-8. PubMed ID: 7159214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.